Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FX7Z4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,524
Award facts
- Contract value 100% obligated
- $15,524.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,524.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 22, 2025, for the supply of Botox 200 Unit Vials. This delivery order does not utilize a set-aside designation and has an ultimate completion date of October 14, 2025. The work will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the prime contractor with no identified subcontractors for this delivery.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs at Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company has maintained consistent federal contracting relationships with the DLA since its registration in SAM.gov in 2001.
Quick answers
Who was awarded contract SPE2DB25FX7Z4?
SPE2DB25FX7Z4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FX7Z4 worth?
The government has obligated $15,524 on SPE2DB25FX7Z4.
Is contract SPE2DB25FX7Z4 an order under another contract?
Yes. SPE2DB25FX7Z4 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Z4 competed?
The extent of competition for SPE2DB25FX7Z4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award